Heart Failure Management and Hospitalization Outcomes

Heart failure remains a leading cause of morbidity, mortality and healthcare expenditure worldwide. Effective management combines pharmacological therapy, device interventions and structured care pathways to stabilise patients, reduce symptom burden and prevent rehospitalization. Guideline‐directed medical therapy—comprising agents such as angiotensin‐converting enzyme inhibitors, beta-blockers, mineralocorticoid receptor antagonists and, more recently, sodium–glucose cotransporter-2 inhibitors—has demonstrable impact on survival and quality of life. Beyond medication, multidisciplinary approaches encompassing specialist nursing, pharmacist review and early follow-up are critical to ensure adherence, optimise fluid status and adjust treatment. Hospitalisation for decompensated heart failure marks periods of heightened vulnerability; post-discharge outcomes depend on both patient factors (comorbidity burden, functional status) and system factors (care transitions, organisational pathways). Advances in risk stratification, predictive modelling and care bundles aim to personalise interventions, shorten length of stay and lower readmission and mortality rates, thereby improving global outcomes in this complex syndrome.

Research from Nature Portfolio

A retrospective study analysed in-hospital trajectories for acute heart failure, clustering care pathways according to ward transfers, diagnostic procedures and discharge plans. One group, described as having a “chaotic” pathway, was characterised by frequent transfers between specialised units and irregular diagnostic sequencing. Patients in this chaotic cluster exhibited significantly higher rates of one-year readmission for heart failure compared with those following more conventional cardiology or gerontology pathways. This work highlights the prognostic importance of organisational factors and supports targeted quality improvement efforts to streamline in-hospital processes and reduce long-term rehospitalisation.

Heart Failure Management and Hospitalization Outcomes publication trend

The graph below shows the total number of articles in heart failure management and hospitalization outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Ejection fraction (EF): The percentage of blood pumped out of the left ventricle with each contraction, used to classify heart failure as preserved (≥50%) or reduced (<40%).

NT-proBNP: N-terminal pro-B-type natriuretic peptide, a biomarker released by ventricular myocardium in response to wall stress, used in diagnosis and risk stratification.

Care bundle: A structured set of evidence-based practices delivered collectively and reliably to improve patient outcomes during hospitalisation.

In-hospital care pathway: The planned sequence of clinical interventions, ward transfers and diagnostics that a patient follows during a hospital stay.

Vulnerable Elders Survey 13 (VES-13): A 13-item questionnaire assessing functional vulnerability, predicting post-discharge healthcare utilisation and adverse outcomes.

References

1. Effect of implementing a heart failure admission care bundle on hospital readmission and mortality rates: interrupted time series study. BMJ Quality & Safety (2023).
2. Days Not at Home: Association of Vulnerability with Healthcare Utilization After Hospitalization for Heart Failure. Journal of General Internal Medicine (2024).
3. Hospitalization for acute heart failure: the in-hospital care pathway predicts one-year readmission. Scientific Reports (2020).
4. Tailored risk assessment of 90‐day acute heart failure readmission or all‐cause death to heart failure with preserved versus reduced ejection fraction. Clinical Cardiology (2022).